Baird Financial Group, Inc. Jazz Pharmaceuticals PLC Transaction History

Baird Financial Group, Inc.

$50.2 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$115.19 - $132.77 $11,403 - $13,144	99 Added 1.82%	5,528 $665,000
Q4 2023 Feb 14, 2024	BUY	$114.26 - $136.0 $49,588 - $59,024	434 Added 8.69%	5,429 $667,000
Q3 2023 Nov 13, 2023	BUY	$122.0 - $145.31 $4,514 - $5,376	37 Added 0.75%	4,995 $646,000
Q2 2023 Aug 11, 2023	BUY	$122.5 - $147.16 $607,355 - $729,619	4,958 New	4,958 $614,000
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $51,775 - $65,922	409 Added 1.83%	22,813 $3.04 Million
Q2 2022 Aug 08, 2022	BUY	$141.59 - $168.66 $106,192 - $126,495	750 Added 3.46%	22,404 $3.5 Million
Q1 2022 May 13, 2022	BUY	$129.64 - $160.7 $576,897 - $715,115	4,450 Added 25.87%	21,654 $3.37 Million
Q4 2021 Feb 09, 2022	SELL	$119.87 - $145.67 $26.1 Million - $31.7 Million	-217,840 Reduced 92.68%	17,204 $2.19 Million
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $247,889 - $356,090	1,927 Added 0.83%	235,044 $30.6 Million
Q2 2021 Aug 11, 2021	BUY	$160.2 - $186.42 $79,299 - $92,277	495 Added 0.21%	233,117 $41.4 Million
Q1 2021 May 13, 2021	SELL	$150.19 - $173.5 $2.31 Million - $2.67 Million	-15,405 Reduced 6.21%	232,622 $38.2 Million
Q4 2020 Feb 11, 2021	SELL	$140.71 - $165.05 $465,468 - $545,985	-3,308 Reduced 1.32%	248,027 $40.9 Million
Q3 2020 Nov 12, 2020	SELL	$105.46 - $144.13 $953,991 - $1.3 Million	-9,046 Reduced 3.47%	251,335 $35.8 Million
Q2 2020 Oct 22, 2020	SELL	$95.68 - $121.88 $1.26 Million - $1.61 Million	-13,188 Reduced 4.82%	260,381 $28.7 Million
Q2 2020 Aug 14, 2020	BUY	$95.68 - $121.88 $341,768 - $435,355	3,572 Added 1.32%	273,569 $40.8 Million
Q1 2020 May 14, 2020	SELL	$87.74 - $152.74 $581,803 - $1.01 Million	-6,631 Reduced 2.4%	269,997 $26.9 Million
Q4 2019 Feb 14, 2020	SELL	$117.65 - $153.73 $2.77 Million - $3.62 Million	-23,554 Reduced 7.85%	276,628 $41.3 Million
Q3 2019 Nov 14, 2019	SELL	$125.18 - $143.24 $1.52 Million - $1.74 Million	-12,140 Reduced 3.89%	300,182 $38.5 Million
Q2 2019 Aug 14, 2019	BUY	$125.55 - $144.48 $1.09 Million - $1.25 Million	8,643 Added 2.85%	312,322 $44.5 Million
Q1 2019 May 14, 2019	BUY	$121.81 - $142.95 $1.55 Million - $1.82 Million	12,746 Added 4.38%	303,679 $43.4 Million
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $409,500 - $588,925	3,532 Added 1.23%	290,933 $36.1 Million
Q3 2018 Nov 13, 2018	SELL	$161.01 - $180.57 $37,676 - $42,253	-234 Reduced 0.08%	287,401 $47.6 Million
Q2 2018 Aug 13, 2018	BUY	$146.33 - $183.18 $7.88 Million - $9.86 Million	53,848 Added 23.03%	287,635 $49.6 Million
Q1 2018 May 14, 2018	BUY	$135.59 - $157.16 $7.73 Million - $8.96 Million	57,025 Added 32.26%	233,787 $35.3 Million
Q4 2017 Feb 09, 2018	SELL	$131.06 - $150.39 $990,027 - $1.14 Million	-7,554 Reduced 4.1%	176,762 $23.8 Million
Q3 2017 Nov 14, 2017	SELL	$142.62 - $155.6 $1.38 Million - $1.5 Million	-9,655 Reduced 4.98%	184,316 $27 Million
Q2 2017 Aug 14, 2017	BUY	N/A	193,971	193,971 $30.2 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account